These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 7543133)

  • 1. Distinct roles for CD28 and cytotoxic T lymphocyte-associated molecule-4 receptors during T cell activation?
    Linsley PS
    J Exp Med; 1995 Aug; 182(2):289-92. PubMed ID: 7543133
    [No Abstract]   [Full Text] [Related]  

  • 2. The emerging role of CTLA-4 as an immune attenuator.
    Thompson CB; Allison JP
    Immunity; 1997 Oct; 7(4):445-50. PubMed ID: 9354465
    [No Abstract]   [Full Text] [Related]  

  • 3. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
    Krummel MF; Allison JP
    J Exp Med; 1995 Aug; 182(2):459-65. PubMed ID: 7543139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Negative co-receptors on lymphocytes.
    Greenwald RJ; Latchman YE; Sharpe AH
    Curr Opin Immunol; 2002 Jun; 14(3):391-6. PubMed ID: 11973140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting edge: the relative distribution of T cells responding to chemically dominant or minor epitopes of lysozyme is not affected by CD40-CD40 ligand and B7-CD28-CTLA-4 costimulatory pathways.
    DiPaolo RJ; Unanue ER
    J Immunol; 2002 Sep; 169(6):2832-6. PubMed ID: 12218093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CD28-B7 costimulatory pathway and its role in autoimmune disease.
    Daikh D; Wofsy D; Imboden JB
    J Leukoc Biol; 1997 Aug; 62(2):156-62. PubMed ID: 9261329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of B7.1-CD28/CTLA-4-mediated co-stimulation in human NK cells.
    Lang S; Vujanovic NL; Wollenberg B; Whiteside TL
    Eur J Immunol; 1998 Mar; 28(3):780-6. PubMed ID: 9541571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD28, CTLA4, CD80, and CD86 molecules in patients with autoimmune rheumatic diseases: implications for immunotherapy.
    Sfikakis PP; Via CS
    Clin Immunol Immunopathol; 1997 Jun; 83(3):195-8. PubMed ID: 9175907
    [No Abstract]   [Full Text] [Related]  

  • 9. CD28/CTLA-4 receptor structure, binding stoichiometry and aggregation during T-cell activation.
    Linsley PS; Ledbetter J; Peach R; Bajorath J
    Res Immunol; 1995; 146(3):130-40. PubMed ID: 8525042
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of CD28-B7 T-cell costimulatory activation pathway affects intragraft cytokine and growth factor expression in chronic renal allograft rejection.
    Nadeau K; Azuma H; Chandraker A; Sayegh MH; Tilney NL
    Transplant Proc; 1997; 29(1-2):1038. PubMed ID: 9123187
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of B7-CD28/CTLA-4 costimulation and NF-kappa B in allergen-induced T cell chemotaxis by IL-16 and RANTES.
    Hidi R; Riches V; Al-Ali M; Cruikshank WW; Center DM; Holgate ST; Djukanovic R
    J Immunol; 2000 Jan; 164(1):412-8. PubMed ID: 10605037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergy between cyclosporin A and a monoclonal antibody to B7 in blocking alloantigen-induced T-cell activation.
    Van Gool SW; Ceuppens JL; Walter H; de Boer M
    Blood; 1994 Jan; 83(1):176-83. PubMed ID: 7506079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients.
    García-Cózar FJ; Molina IJ; Cuadrado MJ; Marubayashi M; Peña J; Santamaría M
    Clin Exp Immunol; 1996 Apr; 104(1):72-9. PubMed ID: 8603537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blocking of the B7-CD28 pathway increases apoptosis induced in activated T cells by in vitro-generated CD95L (FasL) positive dendritic cells.
    Lu L; Qian S; Hershberger P; Rudert WA; Li Y; Chambers FG; Starzl TE; Lynch DH; Thomson AW
    Transplant Proc; 1997; 29(1-2):1094-5. PubMed ID: 9123216
    [No Abstract]   [Full Text] [Related]  

  • 15. CTLA-4 and T cell activation.
    Oosterwegel MA; Greenwald RJ; Mandelbrot DA; Lorsbach RB; Sharpe AH
    Curr Opin Immunol; 1999 Jun; 11(3):294-300. PubMed ID: 10375557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the CD28-B7 costimulatory pathways in T cell-dependent B cell responses.
    Hathcock KS; Hodes RJ
    Adv Immunol; 1996; 62():131-66. PubMed ID: 8781268
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of co-stimulation in airway inflammation.
    Djukanovic R
    Clin Exp Allergy; 2000 Jun; 30 Suppl 1():46-50. PubMed ID: 10849475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: Cbl-b: one of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation.
    Li D; Gál I; Vermes C; Alegre ML; Chong AS; Chen L; Shao Q; Adarichev V; Xu X; Koreny T; Mikecz K; Finnegan A; Glant TT; Zhang J
    J Immunol; 2004 Dec; 173(12):7135-9. PubMed ID: 15585834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking CD28/B7 with soluble competitors: immunological phenotype of mCTLA4-H gamma 1 transgenic mice.
    Lane P
    Res Immunol; 1995; 146(3):176-9. PubMed ID: 8525050
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential roles of IL-16 and CD28/B7 costimulation in the generation of T-lymphocyte chemotactic activity in the bronchial mucosa of mild and moderate asthmatic individuals.
    Dent G; Hosking LA; Lordan JL; Steel MD; Cruikshank WW; Center DM; Ellis JH; Holgate ST; Davies DE; Djukanović R
    J Allergy Clin Immunol; 2002 Dec; 110(6):906-14. PubMed ID: 12464958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.